Pricing Log in Create free account

KALA BIO, Inc. (KALA) vs NeuroSense Therapeutics Ltd. (NRSN)

KALA BIO, Inc. and NeuroSense Therapeutics Ltd. are both Biotechnology companies. KALA BIO, Inc. is the larger, with a market value of $3.0M against $2.6M — 1.1× the size. Across the 8 metrics below, NeuroSense Therapeutics Ltd. leads on 5 and KALA BIO, Inc. on 3.

Valuation

Metric KALA NRSN Biotechnology median
P/E n/m n/m 10.60
P/S 0.52 n/m 9.40
P/B 0.33 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.04 n/m 9.02
Earnings yield (31,890.31%) (832.79%) (32.88%)
Free cash flow yield (667.16%) (909.43%) (23.13%)

Profitability

Metric KALA NRSN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (345.32%) 0.00% (51.96%)
Return on assets (43.23%) 0.00% (46.06%)
Return on invested capital (722.69%) 0.00% 0.00%

Growth

Metric KALA NRSN Biotechnology median
Revenue growth (TTM) (50.54%) — 6.76%
EPS growth (last fiscal year) 67.39% 18.52% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KALA NRSN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.88 0.28 4.97
Net debt to EBITDA 0.19 0.01 1.01

Dividend

Metric KALA NRSN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KALA NRSN Biotechnology median
Market cap 2.95m 2.64m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack